PANDEY SANJAY sold $21K of DGICA

PANDEY SANJAY (Sr. VP & Chief Info Officer) sold 1,070 shares of DONEGAL GROUP INC (DGICA) at $19.52 on 2026-11-05.

Original reporting
SEC EDGAR · PANDEY SANJAY
Published Nov 9, 2026, 1:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 1:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
high confidence
Mentioned
$DGICA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

A small insider sell typically has limited impact but may be noted by short‑term traders.

02

Market read

The filing provides a fresh, primary‑source disclosure of a minor insider sale, offering limited trading relevance.

03

What to watch

Potential upcoming corporate actions or insider expectations not disclosed.

Relevance 3/10Novelty 3/10Timing: filing date 2026-11-09

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$DGICANeutralHigh confidence
Context

Senior VP sold 1,070 shares for $20.9K, reducing his stake to 8,697 shares.

Expected impact

likely slight downward pressure as market prices in the insider sell.

Evidence & confidence

The transaction is small relative to float and does not signal material concerns, but any insider sell can prompt short‑term caution.

Market effects

None; the sale is company‑specific and does not affect the broader sector.

None; limited to the individual stock.

None

Counterpoint

The sale size is negligible; investors may ignore it.

Key entities

  • Donegal Group Inc

    US‑listed biotech firm (ticker DGICA).

  • Sanjay Pandey

    Senior VP & Chief Information Officer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o